Analyst Ratings for Imperva (IMPV)
IMPV Rating Summary
IMPV Price Target Summary
- Highest: $39.00 (Oppenheimer)
- Lowest: $31.00 (Deutsche Bank)
- Average: $34.56
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$34.56 (-12%)
Avg. $ Target:
$34.56 (-12%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/11/2013 | B. Riley | New Coverage | Buy (N/A) |
39.00 (N/A) |
33.82 | 39.29 | 16.17% | Details |
| 1/8/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
32.77 | 39.29 | 19.9% | Details |
| 12/4/2012 | Oppenheimer » Updated 2/8/2013 |
New Coverage | Outperform (N/A) |
39.00 (37.00) |
31.12 | 39.29 | 26.25% | Details |
| 7/19/2012 | ThinkEquity | New Coverage | Buy (N/A) |
35.00 (N/A) |
26.93 | 39.29 | 45.9% | Details |
| 7/11/2012 | Wedbush | New Coverage | Neutral (N/A) |
34.00 (N/A) |
29.46 | 39.29 | 33.37% | Details |
| 7/6/2012 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
28.84 | 39.29 | 36.23% | Details |
| 12/19/2011 | Pacific Crest | New Coverage | Outperform (N/A) |
35.00 (N/A) |
25.74 | 39.29 | 52.64% | Details |
| 12/19/2011 | RBC Capital | New Coverage | Outperform (N/A) |
35.00 (N/A) |
25.74 | 39.29 | 52.64% | Details |
| 12/19/2011 | Lazard Capital | New Coverage | Buy (N/A) |
32.00 (N/A) |
25.74 | 39.29 | 52.64% | Details |
| 12/19/2011 | JPMorgan | New Coverage | Overweight (N/A) |
31.00 (N/A) |
25.74 | 39.29 | 52.64% | Details |
| 12/19/2011 | Deutsche Bank | New Coverage | Buy (N/A) |
31.00 (N/A) |
25.74 | 39.29 | 52.64% | Details |
